id | C00002644 |
---|---|
Name | Catechol / Pyrocatechol |
CAS RN | 120-80-9 |
Standard InChI | InChI=1S/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8H |
Standard InChI (Main Layer) | InChI=1S/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8H |
Phytochemical cluster | No. 82 |
---|---|
KCF-S cluster | No. 1590 |
By standard InChI | CHEMBL280998 |
---|---|
By standard InChI Main Layer | CHEMBL280998 |
By LinkDB | C00090 |
---|
By CAS RN | C034221 |
---|
class name | count |
---|---|
rosids | 4 |
Magnoliophyta | 2 |
Liliopsida | 2 |
asterids | 1 |
family name | count |
---|---|
Anacardiaceae | 1 |
Salicaceae | 1 |
Lauraceae | 1 |
Ericaceae | 1 |
Posidoniaceae | 1 |
Rutaceae | 1 |
Orchidaceae | 1 |
Schisandraceae | 1 |
Rosaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL280998 |
CHEMBL1909136
(2)
|
1 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | CHEMBL280998 |
CHEMBL1613805
(1)
CHEMBL1614009
(1)
CHEMBL1614293 (1) |
0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL280998 |
CHEMBL1613842
(1)
|
4 / 2 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL280998 |
CHEMBL1794367
(1)
CHEMBL2114784
(1)
|
1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL280998 |
CHEMBL1794499
(1)
|
2 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | CHEMBL280998 |
CHEMBL1664429
(1)
|
0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL280998 |
CHEMBL1909139
(2)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL280998 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL280998 |
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL280998 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL280998 |
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL280998 |
CHEMBL1909201
(2)
|
0 / 0 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL280998 |
CHEMBL1614079
(1)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL280998 |
CHEMBL1909176
(2)
|
0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | CHEMBL280998 |
CHEMBL992755
(1)
CHEMBL1074270
(1)
|
0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | CHEMBL280998 |
CHEMBL992754
(1)
CHEMBL1074269
(1)
|
0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | CHEMBL280998 |
CHEMBL992757
(1)
CHEMBL1074272
(1)
|
0 / 0 |
P22894 | Neutrophil collagenase | M10A | CHEMBL280998 |
CHEMBL1664434
(1)
|
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL280998 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL280998 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL280998 |
CHEMBL1909199
(2)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL280998 |
CHEMBL1664435
(1)
CHEMBL1909197
(2)
|
2 / 2 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL280998 |
CHEMBL1794585
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL280998 |
CHEMBL1614310
(1)
CHEMBL1614544
(1)
|
11 / 10 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | CHEMBL280998 |
CHEMBL845695
(1)
|
1 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL280998 |
CHEMBL933690
(1)
CHEMBL991856
(1)
CHEMBL1074266 (1) CHEMBL1909123 (2) CHEMBL1948547 (1) |
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL280998 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL280998 |
CHEMBL1909169
(2)
|
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL280998 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL280998 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL280998 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL280998 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL280998 |
CHEMBL1909090
(2)
|
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL280998 |
CHEMBL1909093
(2)
|
0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL280998 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL280998 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL280998 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL280998 |
CHEMBL1909135
(2)
|
0 / 1 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | CHEMBL280998 |
CHEMBL2318585
(1)
|
1 / 1 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL280998 |
CHEMBL1614522
(1)
CHEMBL1614067
(1)
|
1 / 2 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL280998 |
CHEMBL1909203
(2)
|
1 / 11 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL280998 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL280998 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL280998 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL280998 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL280998 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL280998 |
CHEMBL1909214
(2)
|
0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | CHEMBL280998 |
CHEMBL992756
(1)
CHEMBL1074271
(1)
CHEMBL1948549 (1) |
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL280998 |
CHEMBL1909175
(2)
|
0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL280998 |
CHEMBL1909096
(2)
|
1 / 1 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | CHEMBL280998 |
CHEMBL1613800
(1)
|
0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL280998 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL280998 |
CHEMBL1909166
(2)
|
1 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | CHEMBL280998 |
CHEMBL981174
(1)
CHEMBL1074276
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL280998 |
CHEMBL1614458
(2)
|
0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | CHEMBL280998 |
CHEMBL992759
(1)
CHEMBL1074274
(1)
|
1 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL280998 |
CHEMBL1909133
(2)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL280998 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL280998 |
CHEMBL1613922
(1)
CHEMBL1794486
(1)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL280998 |
CHEMBL1613941
(1)
CHEMBL2114843
(1)
|
0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | CHEMBL280998 |
CHEMBL1613838
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL280998 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL280998 |
CHEMBL1909088
(2)
|
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL280998 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL280998 |
CHEMBL1909101
(2)
|
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL280998 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL280998 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL280998 |
CHEMBL1909146
(2)
|
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL280998 |
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL280998 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL280998 |
CHEMBL1909100
(2)
|
0 / 0 |
P10145 | Interleukin-8 | Secreted protein | CHEMBL280998 |
CHEMBL2114835
(1)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL280998 |
CHEMBL1909167
(2)
|
1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | CHEMBL280998 |
CHEMBL933689
(1)
CHEMBL991855
(1)
CHEMBL1074265 (1) CHEMBL1948546 (1) |
0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL280998 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL280998 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL280998 |
CHEMBL1909110
(2)
|
1 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL280998 |
CHEMBL1664431
(1)
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL280998 |
CHEMBL1909119
(2)
|
0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL280998 |
CHEMBL1794569
(1)
|
1 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | CHEMBL280998 |
CHEMBL1614280
(1)
|
0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL280998 |
CHEMBL1738610
(1)
CHEMBL1794401
(1)
|
0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | CHEMBL280998 |
CHEMBL1963863
(1)
|
0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | CHEMBL280998 |
CHEMBL1963893
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL280998 |
CHEMBL1794382
(1)
CHEMBL1909150
(2)
|
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL280998 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL280998 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL280998 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL280998 |
CHEMBL1909109
(2)
|
2 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL280998 |
CHEMBL1794510
(1)
|
5 / 3 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL280998 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL280998 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL280998 |
CHEMBL1909114
(2)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL280998 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL280998 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL280998 |
CHEMBL1909108
(2)
|
0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | CHEMBL280998 |
CHEMBL1794415
(1)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL280998 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL280998 |
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL280998 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL280998 |
CHEMBL1909132
(2)
|
0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | CHEMBL280998 |
CHEMBL992758
(1)
CHEMBL1074273
(1)
|
0 / 1 |
P08253 | 72 kDa type IV collagenase | M10A | CHEMBL280998 |
CHEMBL1664432
(1)
|
1 / 3 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL280998 |
CHEMBL1613910
(1)
CHEMBL1614227
(2)
|
3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL280998 |
CHEMBL1614038
(2)
|
2 / 2 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | CHEMBL280998 |
CHEMBL1614342
(1)
|
1 / 1 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | CHEMBL280998 |
CHEMBL1614171
(1)
|
5 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | CHEMBL280998 |
CHEMBL2114842
(1)
|
0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL280998 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL280998 |
CHEMBL1794364
(1)
CHEMBL1909145
(2)
|
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL280998 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL280998 |
CHEMBL1909212
(2)
|
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL280998 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL280998 |
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL280998 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL280998 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL280998 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL280998 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL280998 |
CHEMBL1909168
(2)
|
0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL280998 |
CHEMBL1614274
(1)
CHEMBL1613823
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL280998 |
CHEMBL1614240
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL280998 |
CHEMBL1909134
(2)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL280998 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
CHEMBL1909138 (2) |
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL280998 |
CHEMBL1909137
(2)
|
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL280998 |
CHEMBL1794483
(2)
|
0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL280998 |
CHEMBL1737991
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL280998 |
CHEMBL1614283
(1)
CHEMBL1614211
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL280998 |
CHEMBL1614250
(1)
CHEMBL1614421
(1)
CHEMBL1614502 (1) |
4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | CHEMBL280998 |
CHEMBL1738402
(2)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL280998 |
CHEMBL1737980
(1)
CHEMBL2114890
(1)
CHEMBL2114908 (1) |
0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL280998 |
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL280998 |
CHEMBL1909087
(2)
|
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL280998 |
CHEMBL1909213
(2)
|
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL280998 |
CHEMBL1909089
(2)
|
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL280998 |
CHEMBL1909116
(2)
|
1 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | CHEMBL280998 |
CHEMBL991857
(1)
CHEMBL1074267
(1)
|
0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL280998 |
CHEMBL1909206
(2)
|
0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL280998 |
CHEMBL1909128
(2)
|
0 / 0 |
P08254 | Stromelysin-1 | M10A | CHEMBL280998 |
CHEMBL1664433
(1)
|
1 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | CHEMBL280998 |
CHEMBL991858
(1)
CHEMBL1074268
(1)
CHEMBL1948548 (1) |
1 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL280998 |
CHEMBL1794536
(2)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL280998 |
CHEMBL1613914
(1)
|
0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL280998 |
CHEMBL1613829
(1)
|
0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | CHEMBL280998 |
CHEMBL1614086
(1)
CHEMBL1614034
(1)
|
1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL280998 |
CHEMBL1738442
(3)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL280998 |
CHEMBL1614364
(1)
|
1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL280998 |
CHEMBL2354311
(1)
|
1 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | CHEMBL280998 |
CHEMBL2114738
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C034221 | 212 |
ALAS2
ALAS-E ALASE ANH1 ASB XLDPP XLEPP XLSA |
aminolevulinate, delta-, synthase 2 (EC:2.3.1.37) | catechol results in increased expression of ALAS2 mRNA |
increases expression
|
mRNA |
23022512
|
C034221 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Catechin inhibits the reaction [catechol results in increased activity of CASP3 protein] |
decreases reaction
/ increases activity |
protein |
20347921
|
C034221 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | catechol results in increased activity of CASP3 protein |
increases activity
|
protein |
20347921
|
C034221 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Memantine inhibits the reaction [catechol results in increased activity of CASP3 protein] |
decreases reaction
/ increases activity |
protein |
20347921
|
C034221 | 840 |
CASP7
CASP-7 CMH-1 ICE-LAP3 LICE2 MCH3 |
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) | Catechin inhibits the reaction [catechol results in increased activity of CASP7 protein] |
decreases reaction
/ increases activity |
protein |
20347921
|
C034221 | 840 |
CASP7
CASP-7 CMH-1 ICE-LAP3 LICE2 MCH3 |
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) | catechol results in increased activity of CASP7 protein |
increases activity
|
protein |
20347921
|
C034221 | 840 |
CASP7
CASP-7 CMH-1 ICE-LAP3 LICE2 MCH3 |
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) | Memantine inhibits the reaction [catechol results in increased activity of CASP7 protein] |
decreases reaction
/ increases activity |
protein |
20347921
|
C034221 | 6356 |
CCL11
SCYA11 |
chemokine (C-C motif) ligand 11 | catechol results in increased expression of CCL11 protein |
increases expression
|
protein |
17572062
|
C034221 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | catechol results in increased expression of CCL2 protein |
increases expression
|
protein |
17572062
|
C034221 | 6348 |
CCL3
G0S19-1 LD78ALPHA MIP-1-alpha MIP1A SCYA3 |
chemokine (C-C motif) ligand 3 | catechol results in increased expression of CCL3 protein |
increases expression
|
protein |
17572062
|
C034221 | 6351 |
CCL4
ACT2 AT744.1 G-26 HC21 LAG-1 LAG1 MIP-1-beta MIP1B MIP1B1 SCYA2 SCYA4 |
chemokine (C-C motif) ligand 4 | catechol results in increased expression of CCL4 protein |
increases expression
|
protein |
17572062
|
C034221 | 6352 |
CCL5
D17S136E RANTES SCYA5 SIS-delta SISd TCP228 eoCP |
chemokine (C-C motif) ligand 5 | catechol results in increased expression of CCL5 protein |
increases expression
|
protein |
17572062
|
C034221 | 1312 |
COMT
|
catechol-O-methyltransferase (EC:2.1.1.6) | COMT protein results in increased methylation of catechol |
increases methylation
|
protein |
11160877
|
C034221 | 1571 |
CYP2E1
CPE1 CYP2E P450-J P450C2E |
cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) | [CYP2E1 protein affects the metabolism of Benzene] which affects the chemical synthesis of catechol |
affects chemical synthesis
/ affects metabolic processing |
protein |
15051535
|
C034221 | 2623 |
GATA1
ERYF1 GATA-1 GF-1 GF1 NF-E1 NFE1 XLANP XLTDA XLTT |
GATA binding protein 1 (globin transcription factor 1) | catechol results in increased expression of GATA1 mRNA |
increases expression
|
mRNA |
23022512
|
C034221 | 3043 |
HBB
CD113t-C beta-globin |
hemoglobin, beta | catechol results in decreased methylation of HBB promoter |
decreases methylation
|
promoter |
23022512
|
C034221 | 3043 |
HBB
CD113t-C beta-globin |
hemoglobin, beta | catechol results in increased expression of HBB mRNA |
increases expression
|
mRNA |
23022512
|
C034221 | 3145 |
HMBS
PBG-D PBGD PORC UPS |
hydroxymethylbilane synthase (EC:2.5.1.61) | catechol results in decreased methylation of HMBS promoter |
decreases methylation
|
promoter |
23022512
|
C034221 | 3145 |
HMBS
PBG-D PBGD PORC UPS |
hydroxymethylbilane synthase (EC:2.5.1.61) | catechol results in increased expression of HMBS mRNA |
increases expression
|
mRNA |
23022512
|
C034221 | 3586 |
IL10
CSIF GVHDS IL-10 IL10A TGIF |
interleukin 10 | catechol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL10 protein] |
affects cotreatment
/ decreases reaction / increases expression |
protein |
17572062
|
C034221 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | catechol results in increased expression of IL8 protein |
increases expression
|
protein |
15356918
17572062 |
C034221 | 4609 |
MYC
MRTL MYCC bHLHe39 c-Myc |
v-myc avian myelocytomatosis viral oncogene homolog | catechol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MYC protein] |
decreases reaction
/ increases expression |
protein |
12749906
|
C034221 | 1728 |
NQO1
DHQU DIA4 DTD NMOR1 NMORI QR1 |
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) | catechol results in increased expression of NQO1 mRNA |
increases expression
|
mRNA |
8652659
|
C034221 | 6817 |
SULT1A1
HAST1/HAST2 P-PST PST ST1A1 ST1A3 STP STP1 TSPST1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) | SULT1A1 protein results in increased sulfation of catechol |
increases sulfation
|
protein |
17433394
|
C034221 | 6799 |
SULT1A2
HAST4 P-PST ST1A2 STP2 TSPST2 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 (EC:2.8.2.1) | SULT1A2 protein results in increased sulfation of catechol |
increases sulfation
|
protein |
17433394
|
C034221 | 6818 |
SULT1A3
HAST HAST3 M-PST ST1A3/ST1A4 ST1A5 STM TL-PST |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) | SULT1A3 protein results in increased sulfation of catechol |
increases sulfation
|
protein |
17433394
|
C034221 | 6819 |
SULT1C2
ST1C1 ST1C2 SULT1C1 humSULTC2 |
sulfotransferase family, cytosolic, 1C, member 2 (EC:2.8.2.-) | SULT1C2 protein results in increased sulfation of catechol |
increases sulfation
|
protein |
17433394
|
C034221 | 7037 |
TFRC
CD71 T9 TFR TFR1 TR TRFR p90 |
transferrin receptor | catechol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TFRC protein] |
decreases reaction
/ increases expression |
protein |
12749906
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00025 | Penile cancer |
P08253
(related)
P14780 (related) P35354 (related) |
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D002869 | C034221 | Chromosome Aberrations |
marker/mechanism
|
10706450
|
|
D048629 | C034221 | Micronuclei, Chromosome-Defective |
marker/mechanism
|
2676505
19059273 |
|
D009784 | C034221 | Occupational Diseases |
marker/mechanism
|
9930093
|
|
D011041 | C034221 | Poisoning |
marker/mechanism
|
8818868
9930093 |
|
D012640 | C034221 | Seizures |
marker/mechanism
|
7666119
|